Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long-Acting Reversible Contraception | 2 | 2023 | 6 | 1.060 |
Why?
|
| Gonorrhea | 1 | 2025 | 40 | 0.920 |
Why?
|
| Chlamydia Infections | 1 | 2025 | 49 | 0.920 |
Why?
|
| Reproductive Health Services | 1 | 2024 | 19 | 0.900 |
Why?
|
| Sexual Health | 1 | 2023 | 14 | 0.800 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 148 | 0.790 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2025 | 772 | 0.780 |
Why?
|
| Mental Health | 2 | 2023 | 373 | 0.780 |
Why?
|
| Reproductive Health | 1 | 2023 | 48 | 0.770 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2023 | 98 | 0.740 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 718 | 0.620 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2025 | 905 | 0.590 |
Why?
|
| Telemedicine | 1 | 2024 | 503 | 0.570 |
Why?
|
| Sexual Behavior | 3 | 2025 | 251 | 0.550 |
Why?
|
| Young Adult | 7 | 2025 | 9944 | 0.380 |
Why?
|
| Mass Screening | 3 | 2025 | 840 | 0.370 |
Why?
|
| Puberty, Precocious | 1 | 2020 | 29 | 0.340 |
Why?
|
| Adolescent | 9 | 2025 | 20624 | 0.330 |
Why?
|
| Hypothyroidism | 1 | 2020 | 100 | 0.310 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2018 | 76 | 0.260 |
Why?
|
| Pregnancy in Adolescence | 2 | 2025 | 53 | 0.260 |
Why?
|
| Chlamydia trachomatis | 1 | 2025 | 27 | 0.240 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2025 | 16 | 0.240 |
Why?
|
| Depression, Postpartum | 1 | 2025 | 54 | 0.230 |
Why?
|
| Sex Education | 1 | 2023 | 20 | 0.200 |
Why?
|
| Contraceptive Agents, Female | 1 | 2023 | 31 | 0.200 |
Why?
|
| Mouth Mucosa | 1 | 2012 | 54 | 0.190 |
Why?
|
| Chlorhexidine | 1 | 2012 | 49 | 0.190 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2012 | 44 | 0.190 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2012 | 71 | 0.190 |
Why?
|
| Poverty | 1 | 2024 | 438 | 0.180 |
Why?
|
| Reproduction | 1 | 2023 | 245 | 0.170 |
Why?
|
| Humans | 13 | 2025 | 134156 | 0.160 |
Why?
|
| Poliomyelitis | 1 | 2009 | 17 | 0.160 |
Why?
|
| Female | 9 | 2025 | 71928 | 0.160 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 501 | 0.160 |
Why?
|
| Alphavirus Infections | 1 | 2009 | 11 | 0.160 |
Why?
|
| Chikungunya virus | 1 | 2009 | 28 | 0.150 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2009 | 188 | 0.140 |
Why?
|
| Disease Outbreaks | 1 | 2009 | 330 | 0.140 |
Why?
|
| Adult | 3 | 2025 | 31945 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 3999 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2009 | 699 | 0.100 |
Why?
|
| Male | 3 | 2025 | 66127 | 0.080 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2018 | 20 | 0.070 |
Why?
|
| Risk Factors | 1 | 2023 | 11182 | 0.070 |
Why?
|
| Adolescent Medicine | 1 | 2018 | 22 | 0.070 |
Why?
|
| Syndrome | 1 | 2020 | 1167 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 134 | 0.070 |
Why?
|
| Gynecology | 1 | 2018 | 129 | 0.060 |
Why?
|
| Metformin | 1 | 2018 | 165 | 0.060 |
Why?
|
| Endocrinology | 1 | 2018 | 135 | 0.060 |
Why?
|
| Urban Population | 1 | 2025 | 243 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 490 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2025 | 241 | 0.050 |
Why?
|
| Decontamination | 1 | 2012 | 13 | 0.050 |
Why?
|
| Acinetobacter | 1 | 2012 | 9 | 0.050 |
Why?
|
| Comorbidity | 1 | 2018 | 1625 | 0.050 |
Why?
|
| Contraception | 1 | 2023 | 62 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2012 | 143 | 0.050 |
Why?
|
| Focus Groups | 1 | 2023 | 212 | 0.050 |
Why?
|
| Acinetobacter Infections | 1 | 2012 | 36 | 0.050 |
Why?
|
| Pregnancy | 2 | 2025 | 7570 | 0.040 |
Why?
|
| Electrodiagnosis | 1 | 2009 | 10 | 0.040 |
Why?
|
| Hemorrhagic Fevers, Viral | 1 | 2009 | 2 | 0.040 |
Why?
|
| Influenza in Birds | 1 | 2009 | 30 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2009 | 89 | 0.040 |
Why?
|
| Coma | 1 | 2009 | 57 | 0.040 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2009 | 63 | 0.040 |
Why?
|
| Birds | 1 | 2009 | 87 | 0.040 |
Why?
|
| Mexico | 1 | 2009 | 190 | 0.040 |
Why?
|
| Child | 3 | 2018 | 25890 | 0.040 |
Why?
|
| Arthritis | 1 | 2009 | 86 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2684 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 485 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2012 | 1665 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2025 | 17540 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 649 | 0.030 |
Why?
|
| Fever | 1 | 2009 | 312 | 0.030 |
Why?
|
| Length of Stay | 1 | 2012 | 1391 | 0.030 |
Why?
|
| Swine | 1 | 2009 | 1219 | 0.030 |
Why?
|
| United States | 2 | 2023 | 11763 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2012 | 14884 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2009 | 497 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2009 | 824 | 0.030 |
Why?
|
| Infant | 1 | 2012 | 13240 | 0.020 |
Why?
|
| Animals | 1 | 2009 | 36557 | 0.010 |
Why?
|